Literature DB >> 25469266

Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas.

Kristi Ward1, Clarissa Amaya1, Kundan Verma1, Dat Tran1, Dolores Diaz1, Alireza Torabi2, Brad A Bryan1.   

Abstract

Epithelial cell adhesion molecule (EpCAM) is a protein involved in cell-to-cell attachment and is considered to be strictly expressed in epithelial tissues and epithelial-derived tumors. Furthermore, EpCAM has been shown to be a negative prognostic marker for several carcinomas. In this study, we performed a genomic meta-analysis of gene expression profiles housed in the Cancer Cell Line Encyclopedia to demonstrate that EpCAM mRNA is expressed at low to moderate levels in certain sarcoma cell lines. We utilized immunohistochemical staining to confirm that the EpCAM protein is expressed in a subset of angiosarcomas and leiomyosarcomas and in all the investigated osteosarcomas. Finally, we conducted a statistical analysis of clinical data to demonstrate that EpCAM protein expression is significantly and directly correlated with the degree of cytological atypia in leiomyosarcomas. In conclusion, this data suggests that, contrary to conventional beliefs, EpCAM is expressed in a subset of sarcomas and is a negative prognostic marker for leiomyosarcomas.

Entities:  

Keywords:  angiosarcoma; cytological atypia; epithelial cell adhesion molecule; leiomyosarcoma; osteosarcoma; sarcoma

Year:  2014        PMID: 25469266      PMCID: PMC4251134          DOI: 10.3892/mco.2014.428

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  30 in total

1.  Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.

Authors:  Hyo Sup Shim; Bo Sung Yoon; Nam Hoon Cho
Journal:  Hum Pathol       Date:  2009-01-20       Impact factor: 3.466

2.  Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Authors:  Gilbert Spizzo; Philip Went; Stephan Dirnhofer; Peter Obrist; Holger Moch; Patrick A Baeuerle; Elisabeth Mueller-Holzner; Christian Marth; Guenther Gastl; Alain G Zeimet
Journal:  Gynecol Oncol       Date:  2006-05-06       Impact factor: 5.482

3.  Structural and functional characterization of the trifunctional antibody catumaxomab.

Authors:  Dirk Chelius; Peter Ruf; Patrick Gruber; Matthias Plöscher; Reinhard Liedtke; Eva Gansberger; Juergen Hess; Michael Wasiliu; Horst Lindhofer
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

4.  EpCAM expression in normal, non-pathological tissues.

Authors:  Eva Schmelzer; Lola M Reid
Journal:  Front Biosci       Date:  2008-01-01

5.  A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells.

Authors:  Ralf Gutzmer; Wei Li; Shaheen Sutterwala; Maria P Lemos; J Ignasi Elizalde; Sandra L Urtishak; Edward M Behrens; Patricia M Rivers; Katia Schlienger; Terri M Laufer; Stephen L Eck; Michael S Marks
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

6.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

7.  Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

Authors:  David B Seligson; Allan J Pantuck; Xueli Liu; Yunda Huang; Steven Horvath; Matthew H T Bui; Ken-ryu Han; Adrian J L Correa; Mervi Eeva; Sheila Tze; Arie S Belldegrun; Robert A Figlin
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

8.  Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Authors:  Meri Varga; Peter Obrist; Stephan Schneeberger; Gilbert Mühlmann; Christina Felgel-Farnholz; Dominic Fong; Mathias Zitt; Thomas Brunhuber; Georg Schäfer; Guenther Gastl; Gilbert Spizzo
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

9.  Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer.

Authors:  Klaus Pietzner; Hannah Woopen; Rolf Richter; Thomas Joens; Elena Ioana Braicu; Desislava Dimitrova; Håkan Mellstedt; Silvia Darb-Esfahani; Carsten Denkert; Horst Lindhofer; Christina Fotopoulou; Jalid Sehouli
Journal:  Int J Gynecol Cancer       Date:  2013-06       Impact factor: 3.437

10.  Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.

Authors:  I Songun; S V Litvinov; C J H van de Velde; S T Pals; J Hermans; J H J M van Krieken
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  5 in total

Review 1.  Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development.

Authors:  Abhijit Pal; Rajiv Shinde; Manuel Selvi Miralles; Paul Workman; Johann de Bono
Journal:  Nat Rev Clin Oncol       Date:  2021-03-24       Impact factor: 66.675

Review 2.  Significance of circulating tumor cells in soft tissue sarcoma.

Authors:  Chiara Nicolazzo; Angela Gradilone
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-18       Impact factor: 2.916

3.  EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.

Authors:  P B A A van Driel; M C Boonstra; H A J M Prevoo; M van de Giessen; T J A Snoeks; Q R J G Tummers; S Keereweer; R A Cordfunke; A Fish; J D H van Eendenburg; B P F Lelieveldt; J Dijkstra; C J H van de Velde; P J K Kuppen; A L Vahrmeijer; C W G M Löwik; C F M Sier
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

4.  Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices.

Authors:  Henrietta O Fasanya; Pablo J Dopico; Zachary Yeager; Z Hugh Fan; Dietmar W Siemann
Journal:  J Bone Oncol       Date:  2021-03-24       Impact factor: 4.491

Review 5.  The Challenges of Detecting Circulating Tumor Cells in Sarcoma.

Authors:  Marta Tellez-Gabriel; Hannah K Brown; Robin Young; Marie-Françoise Heymann; Dominique Heymann
Journal:  Front Oncol       Date:  2016-09-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.